Factors Associated with Physicians' Reliance on Pharmaceutical Sales Representatives

Academic Medicine

Volumn 84, Issue 8, 2009, Pages 994-1002

  Anderson, Britta L ^a   Silverman, Gabriel K ^b   Loewenstein, George F ^b   Zinberg, Stanley ^a   Schulkin, Jay ^a  

^a AMERICAN UNIVERSITY   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG INFORMATION; FEMALE; GYNECOLOGY; HUMAN; HUMAN RELATION; MALE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; PARAMEDICAL PROFESSION; PHARMACEUTICAL SALES REPRESENTATIVE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; UNITED STATES;

EID: 68949196324     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACM.0b013e3181ace53a     Document Type: Article

References (27)

1. Fugh-Berman A, Ahari S. Following the script: How drug reps make friends and influence doctors. PLoS Med. 2007;4:4:el50.
2. Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med. 2003;18: 294-297.
3. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: Experts' assessments. Ann Intern Med. 1992; 116:912-919.
4. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sale representatives. JAMA. 1995;273:1296-1298.
5. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch FamMed. 1996;5:201-206.
6. Bower AD, Burkett GL. Family physicians and generic drugs: A study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987;24:612-616.
7. Haayer F. Rational prescribing and sources of information. SocSciMed. 1982;16:2017-2023.
8. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005; 118:881-884.
9. Brotzman GL, Mark DH. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8: 130-134.
10. McCormick BB, Tomlinson G, Brill-Edwards P, Destsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behaviors. JAMA. 2001;286:1994-1999.
11. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med. 2005;20:777-786.
12. American College of Obstetricians and Gynecologists Committee on Ethics. ACOG Committee Opinion No. 401: Relationships with industry. Obstet Gynecol. 2008;111: 799-804.
13. American Medical Association. Clarification of opinion 8.061 "Gifts to physicians from industry." In: Code of Medical Ethics: Current Opinions With Annotations. Chicago, Ill.: AMA; 2002;195-203.
14. American Association of Medical Colleges. Industry Funding of Medical Education: Report of an AAMC Task Force. Washington, DC: AAMC; 2008.
15. Farquhar CM, Kofa E, Power ML, Zinberg S, Schulkin J. Clinical practice guidelines as educational tools for obstetrician-gynecologists. J Reprod Med. 2002;47:11:897-902. (Pubitemid 35429891)
16. Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J. Interactions of doctors with the pharmaceutical industry. J Med Ethics. 2006; 32:559-563.
17. Silverman GK, Loewenstein GF, Anderson BL, Ubel PA, Zinberg S, Schulkin J. Failure to discount for conflict of interest when evaluating medical literature: a randomized trial of physicians. Under review.
18. Thomson AN, Craig BJ, Barham PM. Attitudes of general practitioners in New Zealand to pharmaceutical representatives. Br J Gen Pract. 1994;44:220.
19. Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care. 2008;46:394-402.
20. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002;34:729-731.
21. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-483.
22. Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: A nationally representative analysis. Am J Public Health. 2008;98:284-289.
23. Ubel PA, Jepson C, Asch DA. Misperceptions about beta-blockers and diuretics: A national survey of primary care physicians. J Gen Intern Med. 2003;18:977-983.
24. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-154.
25. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2002; 283:3:373-380.
26. Coyle SL. Physician-industry relations. Part 1: Individual physicians. Ann Intern Med. 2002;136: 396-402.
27. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.